<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; Archive</title>
	<atom:link href="http://oralcancernews.org/wp/category/oral_cancer_news/oral-cancer-news-archive/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Fri, 12 Mar 2010 02:25:31 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Risky HPV detected in human breast milk</title>
		<link>http://oralcancernews.org/wp/risky-hpv-detected-in-human-breast-milk/</link>
		<comments>http://oralcancernews.org/wp/risky-hpv-detected-in-human-breast-milk/#comments</comments>
		<pubDate>Sat, 05 Jul 2008 20:29:14 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5751</guid>
		<description><![CDATA[
7/5/2008
New York, NY
Karla Gale
Reuters (www.reuters.com)

Human papillomavirus type 16 (HPV-16), which has been linked to cervical cancer, can be detected in human breast milk collected during the early period after a woman delivers her baby, doctors from Finland report.
It is possible that HPV DNA present in breast milk may be transmitted to the infant during breast [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/risky-hpv-detected-in-human-breast-milk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Advexin moves closer to market</title>
		<link>http://oralcancernews.org/wp/advexin-moves-closer-to-market/</link>
		<comments>http://oralcancernews.org/wp/advexin-moves-closer-to-market/#comments</comments>
		<pubDate>Fri, 04 Jul 2008 20:28:55 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5749</guid>
		<description><![CDATA[
7/4/2008
web-based article
Matthew Dennis
cancerdrugnewsblog.blogspot.com

Introgen Therapeutics has submitted a BLA to the FDA, while simultaneously Gendux Molecular (Introgen) has submitted an MAA to the EMEA, both seeking marketing approval for Advexin (INGN 201), the company&#8217;s targeted p53 tumour suppressor gene therapy, to treat recurrent, refractory head and neck cancer. INGN 201 represents the first in a new [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/advexin-moves-closer-to-market/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Impact of graphic anti-smoking photos burning out</title>
		<link>http://oralcancernews.org/wp/impact-of-graphic-anti-smoking-photos-burning-out-2/</link>
		<comments>http://oralcancernews.org/wp/impact-of-graphic-anti-smoking-photos-burning-out-2/#comments</comments>
		<pubDate>Fri, 04 Jul 2008 20:28:31 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5747</guid>
		<description><![CDATA[
7/4/2008
Ottawa, Ontario, Canada
Sarah Schmidt
Canada.com

Graphic health warnings on cigarette packages are failing to move the majority of smokers to quit, a new government survey has found.
Over the last five years, the percentage of smokers who say the warnings are ineffective at getting them to try to kick the habit has increased, according to the newly released [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/impact-of-graphic-anti-smoking-photos-burning-out-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Seven Major U.S. Cancer Institutions Order Hyperthermia Systems from BSD Medical</title>
		<link>http://oralcancernews.org/wp/seven-major-us-cancer-institutions-order-hyperthermia-systems-from-bsd-medical/</link>
		<comments>http://oralcancernews.org/wp/seven-major-us-cancer-institutions-order-hyperthermia-systems-from-bsd-medical/#comments</comments>
		<pubDate>Thu, 03 Jul 2008 20:28:04 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5745</guid>
		<description><![CDATA[
7/3/2008
Salt Lake City, UT
press release
The Earth Times (www.earthtimes.com)

BSD Medical Corp. today announced the addition of seven new BSD-500 hyperthermia systems purchased by major cancer treatment center in the United States. The most recent purchase by the Massey Cancer Center at Virginia Commonwealth University located in Richmond, Virginia joins in a number of recent hyperthermia system [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/seven-major-us-cancer-institutions-order-hyperthermia-systems-from-bsd-medical/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GSK Does Not Expect FDA Approval Of HPV Vaccine Cervarix Until End Of 2009</title>
		<link>http://oralcancernews.org/wp/gsk-does-not-expect-fda-approval-of-hpv-vaccine-cervarix-until-end-of-2009/</link>
		<comments>http://oralcancernews.org/wp/gsk-does-not-expect-fda-approval-of-hpv-vaccine-cervarix-until-end-of-2009/#comments</comments>
		<pubDate>Thu, 03 Jul 2008 20:27:41 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5743</guid>
		<description><![CDATA[
7/3/2008
web-based article
staff
MedicalNewsToday.com

GlaxoSmithKline on Monday said it does not expect to receive FDA approval for its human papillomavirus vaccine Cervarix until late 2009, Reuters reports. GSK said it has decided to wait until results from a Phase III trial of the vaccine are available before seeking U.S. approval. The study results likely will be submitted to [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/gsk-does-not-expect-fda-approval-of-hpv-vaccine-cervarix-until-end-of-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Laser Surgery Probe Targets Individual Cancer Cells</title>
		<link>http://oralcancernews.org/wp/laser-surgery-probe-targets-individual-cancer-cells/</link>
		<comments>http://oralcancernews.org/wp/laser-surgery-probe-targets-individual-cancer-cells/#comments</comments>
		<pubDate>Tue, 01 Jul 2008 20:27:16 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5741</guid>
		<description><![CDATA[
7/1/2008
Austin, TX
staff
Biocompare (news.biocompare.com)

Mechanical engineering Assistant Professor Adela Ben-Yakar at The University of Texas at Austin has developed a laser &#8220;microscalpel&#8221; that destroys a single cell while leaving nearby cells intact, which could improve the precision of surgeries for cancer, epilepsy and other diseases.
&#8220;You can remove a cell with high precision in 3-D without damaging the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/laser-surgery-probe-targets-individual-cancer-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quit smoking with a proven approach</title>
		<link>http://oralcancernews.org/wp/quit-smoking-with-a-proven-approach/</link>
		<comments>http://oralcancernews.org/wp/quit-smoking-with-a-proven-approach/#comments</comments>
		<pubDate>Tue, 01 Jul 2008 20:26:56 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5739</guid>
		<description><![CDATA[
7/1/2008
Chicago, IL
D. Robert McCaffree, MD
Chicago Tribune (www.chicagotribune.com)

I read with interest the open letter from Dr. Brad Rodu to Sen. Obama in the June 22 Perspective section (&#8221;Quitting ins&#8217;t that easy&#8221;). In this open letter, Dr.Rodu advocated the use of smokeless and spit tobacco (which I will refer to only as spit tobacco) to reduce the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/quit-smoking-with-a-proven-approach/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clay S. Felker, 82 &#8211; Influential Editor of New York Magazine</title>
		<link>http://oralcancernews.org/wp/clay-s-felker-82-influential-editor-of-new-york-magazine/</link>
		<comments>http://oralcancernews.org/wp/clay-s-felker-82-influential-editor-of-new-york-magazine/#comments</comments>
		<pubDate>Tue, 01 Jul 2008 20:26:14 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5737</guid>
		<description><![CDATA[
7/1/2008
Washingon, D.C.
Matt Schudel
Washington Post (www.washingpost.com)

Clay S. Felker, the pioneering editor who founded New York magazine and helped launch the new journalism of the 1960s, with its novelistic techniques and strong point of view, died July 1 at his Manhattan home at 82. He had battled throat cancer in recent years.
&#8220;He had beaten cancer three times,&#8221; [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/clay-s-felker-82-influential-editor-of-new-york-magazine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Leading Medical Teams Rely on SensAble 3D Modeling System to Speed Cranial and Maxillofacial Reconstruction</title>
		<link>http://oralcancernews.org/wp/leading-medical-teams-rely-on-sensable-3d-modeling-system-to-speed-cranial-and-maxillofacial-reconstruction/</link>
		<comments>http://oralcancernews.org/wp/leading-medical-teams-rely-on-sensable-3d-modeling-system-to-speed-cranial-and-maxillofacial-reconstruction/#comments</comments>
		<pubDate>Mon, 30 Jun 2008 20:25:49 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5735</guid>
		<description><![CDATA[
6/30/2008
Cardiff, Wales
press release
www.foxbusiness.com

At the third annual conference on Advanced Digital Technology for Head and Neck Reconstruction today, SensAble Technologies, Inc, a leading provider of touch-enabled modeling solutions and haptic devices, and Majenta Solutions, an Authorized Reseller in the UK, showcased innovative uses of the FreeForm 3D modeling system for quickly creating patient-specific cranial and maxillofacial [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/leading-medical-teams-rely-on-sensable-3d-modeling-system-to-speed-cranial-and-maxillofacial-reconstruction/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Face transplant pioneer in Cardiff</title>
		<link>http://oralcancernews.org/wp/face-transplant-pioneer-in-cardiff/</link>
		<comments>http://oralcancernews.org/wp/face-transplant-pioneer-in-cardiff/#comments</comments>
		<pubDate>Mon, 30 Jun 2008 20:25:22 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5733</guid>
		<description><![CDATA[
6/30/2008
Cardiff, Wales
Madeleine Brindley
Wales Online (www.walesonline.co.uk)

THE leader of the team which carried out the world’s first face transplant will lecture at a major international medical conference to be held in Cardiff.
Professor Bernard Devauchelle, from Amiens, France, made international headlines in 2005 when his team carried out the world’s first face transplant on a 40-year-old French woman, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/face-transplant-pioneer-in-cardiff/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Individualized Treatment Selection in Patients With Head and Neck Cancer &#8211; Do Molecular Markers Meet the Challenge?</title>
		<link>http://oralcancernews.org/wp/individualized-treatment-selection-in-patients-with-head-and-neck-cancer-do-molecular-markers-meet-the-challenge/</link>
		<comments>http://oralcancernews.org/wp/individualized-treatment-selection-in-patients-with-head-and-neck-cancer-do-molecular-markers-meet-the-challenge/#comments</comments>
		<pubDate>Mon, 30 Jun 2008 20:24:54 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5731</guid>
		<description><![CDATA[
6/30/2008
web-based article
Bhuvanesh Singh and David G. Pfister 
Journal of Clinical Oncology, Vol 26, No 19 (July 1), 2008: pp. 3114-3116

Integrated chemotherapy and radiation therapy have become the standard of care for most patients with advanced stage laryngopharyngeal cancers. The concurrent administration of these two modalities is the approach recommended by most experts at present.1 This [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/individualized-treatment-selection-in-patients-with-head-and-neck-cancer-do-molecular-markers-meet-the-challenge/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Knowledge and opinions regarding oral cancer among Maryland dental students</title>
		<link>http://oralcancernews.org/wp/knowledge-and-opinions-regarding-oral-cancer-among-maryland-dental-students/</link>
		<comments>http://oralcancernews.org/wp/knowledge-and-opinions-regarding-oral-cancer-among-maryland-dental-students/#comments</comments>
		<pubDate>Mon, 30 Jun 2008 20:24:32 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5729</guid>
		<description><![CDATA[
6/30/2008
Bethesda, MD
S Boroumand et al.
J Cancer Educ, June 1, 2008; 23(2): 85-91

Background:
Most oral cancers are diagnosed at late stages. Health care providers, particularly dentists, play a critical role in early detection of oral cancers and should be knowledgeable and skillful in oral cancer diagnosis. In this study, we assessed knowledge and opinions regarding oral cancer [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/knowledge-and-opinions-regarding-oral-cancer-among-maryland-dental-students/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prognostic factors of survival in head and neck cancer patients treated with surgery and postoperative radiation therapy</title>
		<link>http://oralcancernews.org/wp/prognostic-factors-of-survival-in-head-and-neck-cancer-patients-treated-with-surgery-and-postoperative-radiation-therapy/</link>
		<comments>http://oralcancernews.org/wp/prognostic-factors-of-survival-in-head-and-neck-cancer-patients-treated-with-surgery-and-postoperative-radiation-therapy/#comments</comments>
		<pubDate>Mon, 30 Jun 2008 20:24:09 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5727</guid>
		<description><![CDATA[
6/30/2008
Clichy, France
C Le Tourneau et al.
Acta Otolaryngol, June 1, 2008; 128(6): 706-12

Conclusions:
Given that radiation therapy (RT) is currently initiated as soon as possible after surgery, our results indicate that the main prognostic factors of survival are pT and pN stages in patients treated with surgery and postoperative RT for locally advanced head and neck squamous [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/prognostic-factors-of-survival-in-head-and-neck-cancer-patients-treated-with-surgery-and-postoperative-radiation-therapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chemoselection As a Strategy for Organ Preservation in Advanced Oropharynx Cancer</title>
		<link>http://oralcancernews.org/wp/chemoselection-as-a-strategy-for-organ-preservation-in-advanced-oropharynx-cancer/</link>
		<comments>http://oralcancernews.org/wp/chemoselection-as-a-strategy-for-organ-preservation-in-advanced-oropharynx-cancer/#comments</comments>
		<pubDate>Mon, 30 Jun 2008 20:23:48 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5725</guid>
		<description><![CDATA[
6/30/2008
Ann Arbor, MI
Francis P. Worden et al.
Journal of Clinical Oncology, Vol 26, No 19 (July 1), 2008: pp. 3138-3146

Response and Survival Positively Associated With HPV16 Copy Number
Purpose:
To test induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CRT) or surgery/radiotherapy (RT) for advanced oropharyngeal cancer and to assess the effect of human papilloma virus (HPV) on response [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/chemoselection-as-a-strategy-for-organ-preservation-in-advanced-oropharynx-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetically engineered viruses battle cancer</title>
		<link>http://oralcancernews.org/wp/genetically-engineered-viruses-battle-cancer/</link>
		<comments>http://oralcancernews.org/wp/genetically-engineered-viruses-battle-cancer/#comments</comments>
		<pubDate>Sun, 29 Jun 2008 20:23:15 +0000</pubDate>
		<dc:creator>mykel</dc:creator>
				<category><![CDATA[Archive]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=5723</guid>
		<description><![CDATA[
6/29/2008
Washington, DC
Robert Boyd
origin.montereyherald.com

Viruses aren&#8217;t always the bad guys. Sure, they can cause colds, measles, AIDS and other miseries. But with some tinkering, these tiny organisms may become a new and better way to treat cancer.
In the last few years, scientists have been genetically engineering various viruses so they attack cancer cells but leave healthy cells [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/genetically-engineered-viruses-battle-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
